Mesenchymal Stem/Stromal Cells in Immunity and Disease: A Better Understanding for an Improved Use
Open Access
- 18 May 2020
- journal article
- editorial
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (5), 1516
- https://doi.org/10.3390/jcm9051516
Abstract
In this Special Issue, directed and supervised by Dr. Mehdi Najar, a collection of basic research articles and reviews, on the state of the art of Mesenchymal Stem/Stromal Cells (MSCs) immune biology, is presented. Among the major goals of this Special Issue is the presentation of an update about the immunomodulatory properties of MSCs and their capacity to respond to tissue microenvironment changes. MSCs hold great promise in the field of immunotherapy and regenerative medicine. Accordingly, a better understanding of MSC immune biology will improve their therapeutic value and use.Funding Information
- Fonds De La Recherche Scientifique - FNRS (NA)
This publication has 16 references indexed in Scilit:
- The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal CellsJournal of Clinical Medicine, 2020
- Are the Immune Properties of Mesenchymal Stem Cells from Wharton’s Jelly Maintained during Chondrogenic Differentiation?Journal of Clinical Medicine, 2020
- HCMV Infection in a Mesenchymal Stem Cell Niche: Differential Impact on the Development of NK Cells versus ILC3Journal of Clinical Medicine, 2019
- 1,25(OH)2D3 Differently Affects Immunomodulatory Activities of Mesenchymal Stem Cells Depending on the Presence of TNF-α, IL-1β and IFN-γJournal of Clinical Medicine, 2019
- Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton’s Jelly, an Extraembryonic SourceJournal of Clinical Medicine, 2019
- Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I StudyJournal of Clinical Medicine, 2019
- Adipose-Derived Stem Cells from Systemic Sclerosis Patients Maintain Pro-Angiogenic and Antifibrotic Paracrine Effects In VitroJournal of Clinical Medicine, 2019
- Parathyroid Hormone-Related Protein (PTHrP) Accelerates Soluble RANKL Signals for Downregulation of Osteogenesis of Bone Mesenchymal Stem CellsJournal of Clinical Medicine, 2019
- Mesenchymal Stromal Cell-Based Therapy: New Perspectives and ChallengesJournal of Clinical Medicine, 2019
- T-Regulatory Cells Confer Increased Myelination and Stem Cell Activity after Stroke-Induced White Matter InjuryJournal of Clinical Medicine, 2019